EFFICACY OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS IN RELATION TO ITS SERUM LEVEL AND THE PRESENCE OF ANTI-DRUG ANTIBODY
Objective: to assess the relationship of the efficiency of adalimumab (ADA) therapy in early rheumatoid arthritis (RA) with the serum level of the drug and with the presence of antibody (Ab) to it.Subjects and methods. Serum concentration of ADA and Ab against it (μg/ml) were measured using an enzym...
Main Authors: | A. S. Avdeeva, E. N. Aleksandrova, D. E. Karateev, E. L. Luchikhina, A. A. Novikov, M. V. Cherkasova, E. L. Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2014-12-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2007 |
Similar Items
-
CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY)
by: A. S. Avdeeva, et al.
Published: (2014-06-01) -
First expirience of adalimumab administration in Russia: preliminary results of an open 24 week study
by: E L Luchichina, et al.
Published: (2008-10-01) -
ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION
by: N. V. Demidova, et al.
Published: (2018-07-01) -
The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results
by: D E Karateev, et al.
Published: (2012-08-01) -
Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis
by: Ione C.P. Pereira, et al.
Published: (2018-06-01)